2017
DOI: 10.1016/j.drugpo.2017.08.006
|View full text |Cite
|
Sign up to set email alerts
|

From mundane medicines to euphorigenic drugs: How pharmaceutical pleasures are initiated, foregrounded, and made durable

Abstract: Examining how pharmaceuticals are used to induce pleasure presents a unique opportunity for analyzing not only how pleasure is assembled and experienced through distinct consumption practices but also how mundane medicines can become euphorigenic substances. Drawing on qualitative research on the non-medical use of prescription drugs by young adults in the United States, this paper utilizes Actor-Network Theory (ANT) to examine how prescription medicines come to produce pleasure. We suggest that the euphorigen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(2 citation statements)
references
References 36 publications
(43 reference statements)
0
2
0
Order By: Relevance
“…Despite the importance of addressing some risks associated to injection practices, pleasure should also be considered a legitimate topic (Race, 2017; Race et al, 2021) because it is central to the lives and experiences of people who use drugs. Recently, some critical drug scholars have drawn on conceptual elements from different post-structuralist approaches (Bundy & Quintero, 2017; Race, 2017) and assemblage thinking (Cañedo & Moral, 2017; Dennis & Farrugia, 2017), sometimes combining the two (Malins, 2017), to conceptualise pleasure in relation to drugs. In this essay, I combine this critical drug studies perspective with insights from narcofeminism by studying the role of pleasure in the experiences of people who inject drugs, how they interact and negotiate with harm reduction providers and how they deploy resistance strategies to patriarchal approaches to drugs use.…”
Section: Introductionmentioning
confidence: 99%
“…Despite the importance of addressing some risks associated to injection practices, pleasure should also be considered a legitimate topic (Race, 2017; Race et al, 2021) because it is central to the lives and experiences of people who use drugs. Recently, some critical drug scholars have drawn on conceptual elements from different post-structuralist approaches (Bundy & Quintero, 2017; Race, 2017) and assemblage thinking (Cañedo & Moral, 2017; Dennis & Farrugia, 2017), sometimes combining the two (Malins, 2017), to conceptualise pleasure in relation to drugs. In this essay, I combine this critical drug studies perspective with insights from narcofeminism by studying the role of pleasure in the experiences of people who inject drugs, how they interact and negotiate with harm reduction providers and how they deploy resistance strategies to patriarchal approaches to drugs use.…”
Section: Introductionmentioning
confidence: 99%
“…All drugs are inherently ambiguous phenomena, as they can act both as “benevolent cures” and “dangerous toxins” (Keane, 2008). Thus, just as mundane prescription drugs can be transformed into euphoric substances used for pleasure through specific situational contexts and user practices (Bundy & Quintero, 2017), cannabis can be transformed from a euphoric substance into a mundane medicine (Newhart & Dolphin, 2018). In the last decades we have seen a renewed interest in the medical utility of cannabis (Pisanti & Bifulco, 2017; Taylor, 2009), in part due to growing evidence that cannabinoids, the active components of cannabis, are effective in the treatment of chronic pain, spasticity, nausea, and epilepsy (National Academies of Sciences Engineering and Medicine, 2017) and also may be relevant for the treatment of other somatic (Cascio et al, 2017; Toczek & Malinowska, 2018) and mental health conditions (Scherma et al, 2020).…”
Section: Introductionmentioning
confidence: 99%